New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q
Neurology April 25,2024
Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q
Neurology April 25,2024
Australia unprepared to move future Alzheimer's treatment into rapid clinical use

Australia unprepared to move future Alzheimer's treatment into rapid clinical use

by RAND CorporationCredit: CC0 Public DomainAs in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from appro
Neurology April 25,2024
Australia unprepared to move future Alzheimer's treatment into rapid clinical use

Australia unprepared to move future Alzheimer's treatment into rapid clinical use

by RAND CorporationCredit: CC0 Public DomainAs in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from appro
Neurology April 25,2024
Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st
Neurology April 25,2024
Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st
Neurology April 25,2024
Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

by Johns Hopkins University Bloomberg School of Public HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainAnalysis of data captured during a long-term study of agi
Neurology April 25,2024
Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

by Johns Hopkins University Bloomberg School of Public HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainAnalysis of data captured during a long-term study of agi
Neurology April 25,2024
Biogen reanalyzes studies, presses ahead on Alzheimer's drug

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

by Marilynn MarchioneIn this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal ap
Neurology April 25,2024
Biogen reanalyzes studies, presses ahead on Alzheimer's drug

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

by Marilynn MarchioneIn this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal ap
Neurology April 25,2024
Alzheimer's linked to the brain's 'garbage disposal service'

Alzheimer's linked to the brain's 'garbage disposal service'

by Andrew Spence, The LeadPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers in South Australia have found a genetic link between Alzheimer's disease and the
Neurology April 25,2024
Alzheimer's linked to the brain's 'garbage disposal service'

Alzheimer's linked to the brain's 'garbage disposal service'

by Andrew Spence, The LeadPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers in South Australia have found a genetic link between Alzheimer's disease and the
Neurology April 25,2024
Daytime sleepiness linked to Alzheimer's

Daytime sleepiness linked to Alzheimer's

by From Mayo Clinic News Network, Mayo Clinic News NetworkPET scan of a human brain with Alzheimer's disease. Credit: public domainDo you catch yourself yawning during the day and yearning for an
Neurology April 25,2024
Daytime sleepiness linked to Alzheimer's

Daytime sleepiness linked to Alzheimer's

by From Mayo Clinic News Network, Mayo Clinic News NetworkPET scan of a human brain with Alzheimer's disease. Credit: public domainDo you catch yourself yawning during the day and yearning for an
Neurology April 25,2024
Alzheimer's diagnosis, management improved by brain scans

Alzheimer's diagnosis, management improved by brain scans

by Alzheimer's AssociationAmyloid-positive (left) and amyloid-negative (right) PET scans can respectively be used to diagnose or rule out Alzheimer's disease in individuals with memory loss or
Neurology April 25,2024
Alzheimer's diagnosis, management improved by brain scans

Alzheimer's diagnosis, management improved by brain scans

by Alzheimer's AssociationAmyloid-positive (left) and amyloid-negative (right) PET scans can respectively be used to diagnose or rule out Alzheimer's disease in individuals with memory loss or
Neurology April 25,2024
Helping dementia carers make sense of their experiences

Helping dementia carers make sense of their experiences

by Cardiff UniversityCredit: Cardiff UniversityA powerful new animation produced by Cardiff University and narrated by Sir Tony Robinson has laid bare the communication difficulties facing people
Neurology April 25,2024
Helping dementia carers make sense of their experiences

Helping dementia carers make sense of their experiences

by Cardiff UniversityCredit: Cardiff UniversityA powerful new animation produced by Cardiff University and narrated by Sir Tony Robinson has laid bare the communication difficulties facing people
Neurology April 25,2024
TET proteins regulate factors essential for normal antibody production

TET proteins regulate factors essential for normal antibody production

by La Jolla Institute for ImmunologyMutant B cells lacking TET2 and TET3 produce an overabundance of a class of antibody called IgM, whereas normal control B cells churned out more effective antibodie
Immunology & Rheumatology April 24,2024
TET proteins regulate factors essential for normal antibody production

TET proteins regulate factors essential for normal antibody production

by La Jolla Institute for ImmunologyMutant B cells lacking TET2 and TET3 produce an overabundance of a class of antibody called IgM, whereas normal control B cells churned out more effective antibodie
Immunology & Rheumatology April 24,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com